cGxP.wire https://validator.w3.org/feed/docs/rss2.html Can-Fite Reports Positive Final Phase IIa Data for Namodenoson in Advanced Pancreatic Cancer Longeveron Reports Significant Reduction in Major Adverse Cardiac Events in ELPIS II HLHS Trial Roche Reports Survival Gains With Divarasib in Lung Cancer Alebund and R1 Advance AP306 Phase 2b Kidney Trial Serapha Bio Reports Positive Interim Safety and Efficacy Results for SERP-01 in Alpha-1 Antitrypsin Deficiency Innovent Reports IBI363 Data Across Lung and Gastric Cancers Marengo Reports Phase 2 Results for Invikafusp Alfa Intensity Therapeutics Reports Early INVINCIBLE-4 Cancer Data MacroGenics Reports 25% Response Rate for Lorigerlimab in CCGC Pfizer Reports Phase 2 Results for 25-Valent Pediatric Vaccine Frontier Reports FMC-376 Responses in KRAS G12C Lung Cancer Abbott Advances Colorectal Cancer Detection With Oncodetect PureTech Reports Phase 1b LYT-200 Results in High-Risk MDS Ractigen Advances Extrahepatic RNA Delivery With LiCO NovaBridge Reports Mature Phase 1b Data for Givastomig Jazz Pharmaceuticals Reports Long-Term Ziihera Cancer Survival Data Genmab Reports 28.2-Month Median OS With Petosemtamab in HNSCC Amarin Reports EMT2 Trial Survival Benefit With Icosapent Ethyl UCB Funds New Medicine Evaluation Research Chair at Brigham SystImmune and Bristol Myers Squibb Announce Positive PANKU-Lung01 Trial Results AbbVie Wins FDA Approval for SKYRIZI Crohn’s Treatment Lilly Reports New Data on Ovarian Cancer Drug Candidate Boehringer Ingelheim and Microsoft Advance AI Clinical Trials Fortrea and Omico Advance Biomarker-Led Cancer Trials Leads Biolabs Reports 21.8-Month PFS for LBL-034 in Myeloma HUTCHMED Reports SANOVO Phase 3 Results in EGFR-Mutated NSCLC BioNTech and DualityBio Report Phase 3 DYNASTY-Breast02 Results in HER2-Low Metastatic Breast Cancer Kaigene and Celltrion Sign $580.5M KG013 Deal Eikon Reports Updated EIK1001 Data in Phase 2 NSCLC Trial Harbour BioMed Wins China Approval for Batoclimab HUTCHMED and AstraZeneca Report Positive Phase III SAFFRON Results in EGFR-Mutated Lung Cancer American Lung Association Expands Lung Cancer Resources Bristol Myers Squibb Reports Phase 1 Zola-Cel Data in MS Faeth Reports Preclinical PIKTOR Data in Breast Cancer Palleon Reports Phase 2 Results for HLX79/E-602 in Kidney Disease TG Therapeutics Reports Phase 1 Azer-Cel Data in Progressive MS IDEAYA Biosciences Reports Promising IDE849 Cancer Data Gilead to Acquire PepStar’s HCXT-2001 for $1.275 Billion Ionis Partner Roche Reports Positive Phase 3 Sefaxersen Data Genentech Reports Positive Phase 3 Sefaxersen Data in IgAN Vertex Reports Positive Phase 3 Povetacicept Results in IgAN Travere Reports FILSPARI Biomarker Data in IgA Nephropathy AI Proteins and Astellas Sign $400M Miniprotein Deal BeOne Reports Promising Data Across Liver and Lung Cancers CatalYm Reports Positive Phase 2 Visugromab Data in Bladder Cancer Genmab and Incyte Partner on KRAS G12D Colorectal Cancer Trial Nanobiotix Reports Phase 1 Data for JNJ-1900 in Melanoma Immatics Reports Clinical Activity for Two PRAME Cancer Therapies Climb Bio and Mabworks Report Positive CLYM116 Phase 1 Data Summit Therapeutics Showcases Ivonescimab Data at ESMO